featured
Molecular Correlates of Response to Eribulin and Pembrolizumab in HR+ Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
Nat Commun 2021 Sep 21;[EPub Ahead of Print], TE Keenan, JL Guerriero, R Barroso-Sousa, T Li, T O'Meara, A Giobbie-Hurder, N Tayob, J Hu, M Severgnini, J Agudo, I Vaz-Luis, L Anderson, V Attaya, J Park, J Conway, MX He, B Reardon, E Shannon, G Wulf, LM Spring, R Jeselsohn, I Krop, NU Lin, A Partridge, EP Winer, EA Mittendorf, D Liu, EM Van Allen, SM TolaneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.